On June 2, a startup called NewLimit, founded by the crypto billionaire Brian Armstrong, said it had raised a further $435 million, from investors including Peter Thiels Founders Fund, to support what it calls age reprogramming. The company says it is working toward delivering genetic reprogramming instructions to the liver, to treat diseases of that organ
Senescent cells are older, damaged cells that stop dividing but do not die when they should
Evaluation of Micronutrient Status Post Laparoscopic Sleeve Gastrectomy: an Australian Perspective
Where care begins, and how it differs Despite the rise of telehealth, most people who use GLP-1s still enter treatment through traditional medical channels
Wang, Van Zant, Daohong Zhou